163 related articles for article (PubMed ID: 38216210)
1. Leveraging COVID-19 Vaccine Safety Monitoring in Ethiopia and Pakistan to Enhance System-Wide Safety Surveillance.
Hagos AA; Sahile Z; Ahmed W; Phanouvong S
Glob Health Sci Pract; 2024 Feb; 12(Suppl 1):. PubMed ID: 38216210
[TBL] [Abstract][Full Text] [Related]
2. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017.
Masuka JT; Khoza S
BMC Public Health; 2019 Aug; 19(1):1166. PubMed ID: 31455314
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2021.
Glover C; Deng L; Larter C; Brogan C; Richardson O; Huang YA; Kay E; Macartney K; Wood N
Commun Dis Intell (2018); 2024 Jun; 48():. PubMed ID: 38926650
[TBL] [Abstract][Full Text] [Related]
4. [Adverse events following immunization reported with COVID-19 vaccines in Burkina Faso: Analysis of spontaneous reports].
Sawadogo R; Ouoba J; Ilboudo D; Tchoumbi E; Lankoandé-Haro S; Fofana S; Sombié I; Samadoulougou S; Kirakoya-Samadoulougou F
Sante Publique; 2024 Feb; 35(6):149-159. PubMed ID: 38388395
[TBL] [Abstract][Full Text] [Related]
5. Best practice implementation on reporting of coronavirus disease 2019 vaccine adverse events following immunization in Uasin Gishu County, Kenya.
Amdany H; Koech B
JBI Evid Implement; 2023 Jun; 21(2):146-155. PubMed ID: 36545897
[TBL] [Abstract][Full Text] [Related]
6. Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands.
Kant A; Jansen J; van Balveren L; van Hunsel F
Drug Saf; 2022 Apr; 45(4):319-331. PubMed ID: 35314943
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study.
Ferrara F; Mancaniello C; Varriale A; Sorrentino S; Zovi A; Nava E; Trama U; Boccellino M; Vitiello A
Clin Drug Investig; 2022 Dec; 42(12):1065-1074. PubMed ID: 36274082
[TBL] [Abstract][Full Text] [Related]
8. Imprecision in vaccine adverse event reporting and a methodological analysis of reporting systems to improve pharmacovigilance and public health.
Inokuma Y; Kneller R
Eur J Clin Pharmacol; 2023 Jul; 79(7):989-1002. PubMed ID: 37249640
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial.
Nyambayo PPM; Gold MS; Mehta UC; Clarke S; Manyevere R; Chirinda L; Zifamba EN; Nyamandi T
Vaccine; 2023 Oct; 41(45):6700-6709. PubMed ID: 37805357
[TBL] [Abstract][Full Text] [Related]
10. Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000-2015.
Lei J; Balakrishnan MR; Gidudu JF; Zuber PLF
Vaccine; 2018 Mar; 36(12):1577-1582. PubMed ID: 29454518
[TBL] [Abstract][Full Text] [Related]
11. Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India.
Joshi J; Das MK; Polpakara D; Aneja S; Agarwal M; Arora NK
Indian J Pediatr; 2018 Feb; 85(2):139-148. PubMed ID: 29170922
[TBL] [Abstract][Full Text] [Related]
12. Canadian vaccine safety surveillance reports following immunization with seasonal influenza vaccines, 2021-2022.
Giang E; Xu Y; Naganathan T; Abraham N; Bawolak MT; Salim BS; Weeks A; Shaw A; Ogunnaike-Cooke S
Can Commun Dis Rep; 2024 Jan; 50(1-2):16-24. PubMed ID: 38655243
[TBL] [Abstract][Full Text] [Related]
13. Progress in Immunization Safety Monitoring - Worldwide, 2020-2022.
Blau EF; Balakrishnan MR; Sköld H; Santhana Gopala Krishnan RS; Lundquist P; Pal S; Gidudu JF
MMWR Morb Mortal Wkly Rep; 2023 Dec; 72(49):1321-1326. PubMed ID: 38060432
[TBL] [Abstract][Full Text] [Related]
14. Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods Study.
Ogar CK; Quick J; Gilbert HN; Vreman RA; Mantel-Teeuwisse AK; Mugunga JC
Drug Saf; 2023 Apr; 46(4):357-370. PubMed ID: 36811813
[TBL] [Abstract][Full Text] [Related]
15. Comparative safety of mRNA COVID-19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database.
Kim MS; Jung SY; Ahn JG; Park SJ; Shoenfeld Y; Kronbichler A; Koyanagi A; Dragioti E; Tizaoui K; Hong SH; Jacob L; Salem JE; Yon DK; Lee SW; Ogino S; Kim H; Kim JH; Excler JL; Marks F; Clemens JD; Eisenhut M; Barnett Y; Butler L; Ilie CP; Shin EC; Il Shin J; Smith L
J Med Virol; 2022 Mar; 94(3):1085-1095. PubMed ID: 34709664
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune disorders reported following COVID-19 vaccination: A disproportionality analysis using the WHO database.
Kim S; Bea S; Choe SA; Choi NK; Shin JY
Eur J Clin Pharmacol; 2024 Mar; 80(3):445-453. PubMed ID: 38212538
[TBL] [Abstract][Full Text] [Related]
17. Otorhinolaryngologic complications after COVID-19 vaccination, vaccine adverse event reporting system (VAERS).
Shin J; Shim SR; Lee J; Ryu HS; Kim JY
Front Public Health; 2023; 11():1338862. PubMed ID: 38269374
[TBL] [Abstract][Full Text] [Related]
18. Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands.
van der Boor SC; Schmitz-de Vries ETJ; Smits D; Scholl JHG; Rolfes L; van Hunsel F
Vaccine; 2023 Jun; 41(29):4319-4326. PubMed ID: 37286408
[TBL] [Abstract][Full Text] [Related]
19. Artificial Intelligence-Enabled Social Media Analysis for Pharmacovigilance of COVID-19 Vaccinations in the United Kingdom: Observational Study.
Hussain Z; Sheikh Z; Tahir A; Dashtipour K; Gogate M; Sheikh A; Hussain A
JMIR Public Health Surveill; 2022 May; 8(5):e32543. PubMed ID: 35144240
[TBL] [Abstract][Full Text] [Related]
20. Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study.
Mascolo A; di Mauro G; Fraenza F; Gaio M; Zinzi A; Pentella C; Rossi F; Capuano A; Sportiello L
Front Immunol; 2022; 13():965171. PubMed ID: 36263025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
